glp 1 drugs and bipolar disorder An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive mental health disorders Exploring glucagon-like peptide-1 receptor agonists

Read More: #IndiaUKFTA #affordablemedicines #UKmarket #contractmanufacturing #voluntarylicensing #publichealth To view or add a comment, sign in New Drug Approval Alert | Pharminho Drug Repository CDSCO has approved Elobixibat Tablets 10 mg of M/s Exemed Pharmaceuticals for the treatment of Chronic Constipation

This regulatory change effectively prohibited pharmacies from continuing to compound these agents under the exemption based on shortages

( 10.1056/NEJMoa1607141) [DOI] [PubMed] [Google Scholar] Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, et al

If approved, it would become the first hormone replacement therapy to address the underlying cause of hypoparathyroidism

Neurogastroenterol Motil 2017